167 related articles for article (PubMed ID: 16544909)
1. Hyperbranched polymers as drug carriers: microencapsulation and release kinetics.
Suttiruengwong S; Rolker J; Smirnova I; Arlt W; Seiler M; Lüderitz L; Pérez de Diego Y; Jansens PJ
Pharm Dev Technol; 2006 Feb; 11(1):55-70. PubMed ID: 16544909
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the hyperbranched polymer Hybrane H1500 for production of matricial controlled-release particles by hot-melt extrusion.
Raviña-Eirín E; Sánchez-Rodríguez B; Gómez-Amoza JL; Martínez-Pacheco R
Int J Pharm; 2014 Jan; 461(1-2):469-77. PubMed ID: 24368108
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of burst release from pH-responsive polymeric microparticles.
Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
[TBL] [Abstract][Full Text] [Related]
4. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
5. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
7. Drug structural features affect drug delivery from hyperbranched polyesteramide hot melt extrudates.
Raviña-Eirin E; Azuaje J; Sotelo E; Gomez-Amoza JL; Martinez-Pacheco R
Eur J Pharm Biopharm; 2016 May; 102():1-8. PubMed ID: 26912462
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process.
Perinelli DR; Bonacucina G; Cespi M; Naylor A; Whitaker M; Palmieri GF; Giorgioni G; Casettari L
Int J Pharm; 2014 Jul; 468(1-2):250-7. PubMed ID: 24746690
[TBL] [Abstract][Full Text] [Related]
9. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method.
Dong W; Bodmeier R
Int J Pharm; 2006 Dec; 326(1-2):128-38. PubMed ID: 16942845
[TBL] [Abstract][Full Text] [Related]
12. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation.
Zeng J; Yang L; Liang Q; Zhang X; Guan H; Xu X; Chen X; Jing X
J Control Release; 2005 Jun; 105(1-2):43-51. PubMed ID: 15908033
[TBL] [Abstract][Full Text] [Related]
13. Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.
Li S; Liu Y; Liu T; Zhao L; Zhao J; Feng N
Int J Pharm; 2011 Jun; 411(1-2):172-7. PubMed ID: 21511016
[TBL] [Abstract][Full Text] [Related]
14. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
15. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride.
Reven S; Grdadolnik J; Kristl J; Zagar E
Int J Pharm; 2010 Aug; 396(1-2):119-26. PubMed ID: 20600725
[TBL] [Abstract][Full Text] [Related]
16. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
17. Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues.
Asmus LR; Gurny R; Möller M
Int J Artif Organs; 2011 Feb; 34(2):238-42. PubMed ID: 21374569
[TBL] [Abstract][Full Text] [Related]
18. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
[TBL] [Abstract][Full Text] [Related]
19. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
20. Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.
Chiappetta DA; Carcaboso AM; Bregni C; Rubio M; Bramuglia G; Sosnik A
AAPS PharmSciTech; 2009; 10(1):1-6. PubMed ID: 19127436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
